Clinical Trial Update: Clinical Study of Irinotecan Liposome Combination Therapy for Advanced Gastric Cancer [Phase 4]

View source ↗

Summary

A Phase 4 clinical study of liposomal irinotecan in combination therapy for advanced gastric cancer is listed as not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Onivyde (liposomal irinotecan) (liposomal irinotecan)

Snippet

Sponsor: First Affiliated Hospital Xi'an Jiaotong University | Conditions: Gastric Cancer | Phase 4 | Status: NOT_YET_RECRUITING